NDC 70710-1239-01 - acetaZOLAMIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70710-1239
- Requested NDC
- 70710-1239-01
- Package NDCs from labels
- 70710-1239-1, 70710-1239-01
- Manufacturer
- Zydus Pharmaceuticals (USA) Inc. | Zydus Lifesciences Global FZE | Zydus Lifesciences Limited
- Effective date
- 2024-03-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| acetaZOLAMIDE Tablets, USP RX Only | Zydus Pharmaceuticals (USA) Inc. | Zydus Lifesciences Global FZE | Zydus Lifesciences Limited | 2024-03-26 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70710-1239-1 | acetaZOLAMIDE | 100 in 1 BOTTLE | TABLET | 100 | 3 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70710-1239 | ACETAZOLAMIDE TABLET [ZYDUS PHARMACEUTICALS (USA) INC.] | 3 | Current NDC, 1 package rows | 20240328_85e4d8f6-1e82-4068-a768-752287d4ccf2.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acetazolamide | ACETAZOLAMIDE | ANI Pharmaceuticals, Inc. | bde94a48-05d0-45a0-a589-ec05b7d16532 | 2026-01-23 | Warnings, Adverse reactions | 197303 197304 O3FX965V0I |
| Lotrimin Daily Sweat and Odor Control | TOPICAL STARCH | Bayer HealthCare LLC. | 9ec5c80d-b550-496f-e053-2a95a90a5489 | 2026-01-16 | Warnings | O8232NY3SJ |
| Acetazolamide | ACETAZOLAMIDE | AvPAK | a9dca448-5511-413e-e053-2a95a90a8c66 | 2026-01-08 | Warnings, Adverse reactions | 197304 O3FX965V0I |
| Acetazolamide | ACETAZOLAMIDE | PD-Rx Pharmaceuticals, Inc. | c525ef20-ec9a-4ffd-b5ea-e53c186fe716 | 2026-01-05 | Warnings, Adverse reactions | 197303 197304 O3FX965V0I |
| acetazolamide | ACETAZOLAMIDE | Northwind Health Company, LLC | f8232eaf-e108-aa00-e053-6394a90aede4 | 2026-01-01 | Warnings, Adverse reactions | 197303 O3FX965V0I |
| Medicated Cornstarch Baby Powder | ACTIVE CORN STARCH | Davion, Inc. | e39032d1-c8cd-4a41-af10-126970b8ad38 | 2025-12-29 | Warnings | O8232NY3SJ |
| acetazolamide | ACETAZOLAMIDE | Accord Healthcare Inc. | 9a368b35-cd51-47ad-83cc-ccc56c4585e8 | 2025-12-15 | Warnings, Adverse reactions | O3FX965V0I |
| ACETAZOLAMIDE EXTENDED-RELEASE | ACETAZOLAMIDE EXTENDED-RELEASE | Micro Labs Limited | 78f78919-a6ba-4072-bc45-2ab3637ed894 | 2025-12-08 | Warnings, Adverse reactions | O3FX965V0I |
| Acetazolamide | ACETAZOLAMIDE | Aarkish Pharmaceuticals NJ Inc. | ddfd44dc-3136-4dda-8ed0-eb2991c2a0b6 | 2025-12-08 | Warnings, Adverse reactions | 197303 197304 O3FX965V0I |
| Acetazolamide | ACETAZOLAMIDE | Eywa Pharma Inc | c19166fa-2cef-4c96-a956-ea540a8ba9c3 | 2025-12-05 | Warnings, Adverse reactions | 197303 197304 O3FX965V0I |
| Acetazolamide | ACETAZOLAMIDE | Ingenus Pharmaceuticals, LLC | a1f6ed35-9188-4115-8a3c-1ac91c07bf7d | 2025-12-05 | Warnings, Adverse reactions | O3FX965V0I |
| Acetazolamide | ACETAZOLAMIDE | Advagen Pharma Ltd | c24d31f0-a556-4e53-97a9-4e05e28ca40f | 2025-11-12 | Warnings, Adverse reactions | 197303 197304 O3FX965V0I |
| ACETAZOLAMIDE | ACETAZOLAMIDE | Aurobindo Pharma Limited | 513da48f-8f12-4696-b862-e8d882bf8611 | 2025-11-03 | Warnings, Adverse reactions | 197303 197304 O3FX965V0I |
| acetaZOLAMIDE | ACETAZOLAMIDE | Viona Pharmaceuticals Inc | 5473c171-dc2d-4a82-bbf1-0f5fad10f673 | 2025-11-03 | Warnings, Adverse reactions | ANDA211069 197303 197304 O3FX965V0I |
| acetaZOLAMIDE | ACETAZOLAMIDE | Zydus Lifesciences Limited | df84fea3-8947-403f-b470-1eeb6c4c293d | 2025-10-31 | Warnings, Adverse reactions | ANDA211069 197303 197304 O3FX965V0I |
| acetazolamide | ACETAZOLAMIDE | American Health Packaging | 4e8797d9-2e78-49e0-af25-ac5d1f792499 | 2025-05-30 | Warnings, Adverse reactions | O3FX965V0I |
| Acetazolamide | ACETAZOLAMIDE | NuCare Pharmaceuticals,Inc. | 0b76c194-b244-e9ac-e063-6394a90a373e | 2025-02-03 | Warnings, Adverse reactions | 197303 O3FX965V0I |
| Acetazolamide | ACETAZOLAMIDE | NuCare Pharmaceuticlas, Inc. | 278878bc-da9c-09d4-e063-6394a90abaf7 | 2024-11-22 | Warnings, Adverse reactions | 197303 O3FX965V0I |
| Acetazolamide | ACETAZOLAMIDE | Bryant Ranch Prepack | 923031ec-8142-4570-b3a6-210441d97105 | 2024-10-29 | Warnings, Adverse reactions | 197304 O3FX965V0I |
| Acetazolamide | ACETAZOLAMIDE | Chartwell RX, LLC | e8e48a25-5f6c-4b5a-a5f2-ee87aabea33b | 2024-10-10 | Warnings, Adverse reactions | O3FX965V0I |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.